The most active researchers, institutions, and subtopics in CAR-T Cell Therapy, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 600 recent PubMed papers (2021-2026) matching "CAR-T cell therapy hematologic malignancy". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Yu Jianhua | University of California | 8 |
| 2 | Guo Zhigang | College of Life Sciences | 7 |
| 3 | Hudecek Michael | Universitätsklinikum Würzburg | 6 |
| 4 | Aljurf Mahmoud | King Faisal Specialist Hospital and Research Centre | 5 |
| 5 | Xiao Yi | Tongji Hospital | 5 |
| 6 | Ruella Marco | University of Pennsylvania | 5 |
| 7 | Kobold Sebastian | Institute for Clinical Pharmacology | 5 |
| 8 | Rejeski Kai | LMU University Hospital | 5 |
| 9 | Wan Xiaochun | Guangdong Immune Cell Therapy Engineering and Technology R | 5 |
| 10 | Perales Miguel-Angel | Weill Cornell Medical College | 5 |
| 11 | Li Yan-Ruide | University of California | 4 |
| 12 | Li Wenying | College of Life Sciences | 4 |
| 13 | Chen Jiannan | College of Life Sciences | 4 |
| 14 | Gauthier Jordan | Clinical Research Division | 4 |
| 15 | Shadman Mazyar | Clinical Research Division | 4 |
| 16 | Li Yuhua | Zhujiang Hospital | 4 |
| 17 | Paruzzo Luca | University of Pennsylvania | 4 |
| 18 | Delgado Julio | Institut d'Investigacions Biomèdiques August Pi i Sunyer ( | 4 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell (2026) · PMID 42470580
Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell-Associated Neuroto (2026) · PMID 42462106
Lessons Learned: Operationalizing Chimeric Antigen Receptor T-Cell Therapy in the Community Oncology Private Practice Healthcare S (2026) · PMID 42462103
From barrier to trigger: leveraging tumor hypoxia for precise control of CAR-T cell activity. (2026) · PMID 42455334
Cultivating Functional Natural Killer Cells from Mobilized Hematopoietic Stem Cells in Heavily Pretreated Hematologic Malignancies (2026) · PMID 42450110
A full CAR-T Cell Therapy brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.